Drug-tolerant persister cancer cells

被引：1
|
作者：
Wang, Pengliang [1 ,2 ,3 ,4 ]
Ke, Bin [1 ,2 ]
Ma, Gang [1 ,2 ,3 ]
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gastr Surg, Tianjin, Peoples R China
[2] Tianjin Key Lab Digest Canc, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastrointestinal Surg, Guangzhou, Peoples R China
来源：
JOURNAL OF THE NATIONAL CANCER CENTER | 2024年 / 4卷 / 01期
关键词：
RESISTANCE; INHIBITOR; STATE;
D O I：
10.1016/j.jncc.2023.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [1] Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
    Hangauer, Matthew J.
    Viswanathan, Vasanthi S.
    Ryan, Matthew J.
    Bole, Dhruv
    Eaton, John K.
    Matov, Alexandre
    Galeas, Jacqueline
    Dhruv, Harshil D.
    Berens, Michael E.
    Schreiber, Stuart L.
    McCormick, Frank
    McManus, Michael T.
    NATURE, 2017, 551 (7679) : 247 - +
  • [2] Drug-tolerant persister cells in cancer: the cutting edges and future directions
    Pu, Yi
    Li, Lu
    Peng, Haoning
    Liu, Lunxu
    Heymann, Dominique
    Robert, Caroline
    Vallette, Francois
    Shen, Shensi
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (11) : 799 - 813
  • [3] Redox signaling in drug-tolerant persister cells as an emerging therapeutic target
    Zhang, Zhe
    Tan, Yunhan
    Huang, Canhua
    Wei, Xiawei
    EBIOMEDICINE, 2023, 89
  • [4] Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
    Russo, Mariangela
    Chen, Mengnuo
    Mariella, Elisa
    Peng, Haoning
    Rehman, Sumaiyah K.
    Sancho, Elena
    Sogari, Alberto
    Toh, Tzen S.
    Balaban, Nathalie Q.
    Batlle, Eduard
    Bernards, Rene
    Garnett, Mathew J.
    Hangauer, Matthew
    Leucci, Eleonora
    Marine, Jean-Christophe
    O'Brien, Catherine A.
    Oren, Yaara
    Patton, E. Elizabeth
    Robert, Caroline
    Rosenberg, Susan M.
    Shen, Shensi
    Bardelli, Alberto
    NATURE REVIEWS CANCER, 2024, 24 (10) : 694 - 717
  • [5] Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma
    Chavez-Dominguez, Rodolfo
    Aguilar-Cazares, Dolores
    Perez-Medina, Mario
    Avila-Rios, Santiago
    Soto-Nava, Maribel
    Mendez-Tenorio, Alfonso
    Islas-Vazquez, Lorenzo
    Benito-Lopez, Jesus J.
    Galicia-Velasco, Miriam
    Lopez-Gonzalez, Jose S.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Sublethal cytochrome c release generates drug-tolerant persister cells
    Kalkavan, Halime
    Chen, Mark J.
    Crawford, Jeremy C.
    Quarato, Giovanni
    Fitzgerald, Patrick
    Tait, Stephen W. G.
    Goding, Colin R.
    Green, Douglas R.
    CELL, 2022, 185 (18) : 3356 - +
  • [7] Glutathione Peroxidase 4 as a Therapeutic Target for Anti-Colorectal Cancer Drug-Tolerant Persister Cells
    Zhang, Xiaoli
    Ma, Yiming
    Ma, Jianhui
    Yang, Lan
    Song, Qingzhi
    Wang, Hongying
    Lv, Guoqing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Proteomic Landscape of a Drug-Tolerant Persister Subpopulation of Mycobacterium tuberculosis
    Sharma, Rishabh
    Lunge, Ajitesh
    Mangla, Nikita
    Agarwal, Nisheeth
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (09) : 4415 - 4426
  • [9] Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review
    Liang, Xian-Wen
    Liu, Bing-
    Chen, Jia-Cheng
    Cao, Zhi
    Chu, Feng-ran
    Lin, Xiong
    Wang, Sheng-Zhong
    Wu, Jin-Cai
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer
    Nojima, Yosui
    Yao, Ryoji
    Suzuki, Takashi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (03):
12345